Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' BRECHOT C' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 280 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Gozuacik, D; Murakami, Y; Saigo, K; Chami, M; Mugnier, C; Lagorce, D; Okanoue, T; Urashima, T; Brechot, C; Paterlini-Brechot, P
      Identification of human cancer-related genes by naturally occurring Hepatitis B Virus DNA tagging

      ONCOGENE
    2. Delhem, N; Sabile, A; Gajardo, R; Podevin, P; Abadie, A; Blaton, MA; Kremsdorf, D; Beretta, L; Brechot, C
      Activation of the interferon-inducible protein kinase PKR by Hepatocellular carcinoma derived-Hepatitis C virus core protein

      ONCOGENE
    3. Huo, TI; Wang, XW; Forgues, M; Wu, CG; Spillare, EA; Giannini, C; Brechot, C; Harris, CC
      Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis

      ONCOGENE
    4. Gerolami, R; Uch, R; Cardoso, J; Bagnis, C; Mannoni, P; Brechot, C
      Gene therapy for hepatocellular carcinoma. From the idea to clinical trials

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    5. Brechot, C; Thiers, V; Kremsdorf, D; Nalpas, B; Pol, S; Paterlini-Brechot, P
      Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely "occult"?

      HEPATOLOGY
    6. Podevin, P; Sabile, A; Gajardo, R; Delhem, N; Abadie, A; Lozach, PY; Beretta, L; Brechot, C
      Expression of hepatitis C virus NS5A natural mutants in a hepatocytic cellline inhibits the antiviral effect of interferon in a PKR-independent manner

      HEPATOLOGY
    7. Bottazzi, ME; Buzzai, M; Zhu, XY; Desdouets, C; Brechot, C; Assoian, RK
      Distinct effects of mitogens and the actin cytoskeleton on CREB and pocketprotein phosphorylation control the extent and timing of cyclin A promoteractivity

      MOLECULAR AND CELLULAR BIOLOGY
    8. Michel, ML; Pol, S; Brechot, C; Tiollais, P
      Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future

      VACCINE
    9. Nalpas, B; Martin, S; Fontaine, H; Fabbro-Peray, P; Brechot, C; Pol, S
      Impact of medical recommendations on alcohol consumption in HCV positive patients

      JOURNAL OF HEPATOLOGY
    10. Pol, S; Nalpas, B; Driss, F; Michel, ML; Tiollais, P; Denis, J; Brechot, C
      Efficacy and limitations of a specific immunotherapy in chronic hepatitis B

      JOURNAL OF HEPATOLOGY
    11. Fontaine, H; Nalpas, B; Poulet, B; Carnot, F; Zylberberg, H; Brechot, C; Pol, S
      Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C

      HUMAN PATHOLOGY
    12. Gordien, E; Rosmorduc, O; Peltekian, C; Garreau, F; Brechot, C; Kremsdorf, D
      Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein

      JOURNAL OF VIROLOGY
    13. De Beeck, AO; Sobczak-Thepot, J; Sirma, H; Bourgain, F; Brechot, C; Caillet-Fauquet, P
      NS1-and minute virus of mice-induced cell cycle arrest: Involvement of p53and p21(cip1)

      JOURNAL OF VIROLOGY
    14. Soussan, P; Pol, S; Garreau, F; Brechot, C; Kremsdorf, D
      Vaccination of chronic hepatitis B virus carriers with preS2/S envelope protein is not associated with the emergence of envelope escape mutants

      JOURNAL OF GENERAL VIROLOGY
    15. Chami, M; Gozuacik, D; Lagorce, D; Brini, M; Falson, P; Peaucellier, G; Pinton, P; Lecoeur, H; Gougeon, ML; le Maire, M; Rizzuto, R; Brechot, C; Paterlini-Brechot, P
      SERCA1 truncated proteins unable to pump calcium reduce the endoplasmic reticulum calcium concentration and induce apoptosis

      JOURNAL OF CELL BIOLOGY
    16. Faivre, J; Frank-Vaillant, M; Poulhe, R; Mouly, H; Brechot, C; Sobczak-Thepot, J; Jessus, C
      Membrane-anchored cyclin A2 triggers Cdc2 activation in Xenopus oocyte

      FEBS LETTERS
    17. Tu, H; Bonura, C; Giannini, C; Mouly, H; Soussan, P; Kew, M; Paterlini-Brechot, P; Brechot, C; Kremsdorf, D
      Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues

      CANCER RESEARCH
    18. Brechot, C
      Hepatocellular carcinoma - Introduction

      SEMINARS IN CANCER BIOLOGY
    19. Brechot, C; Gozuacik, D; Murakami, Y; Paterlini-Brechot, P
      Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC)

      SEMINARS IN CANCER BIOLOGY
    20. Paterlini-Brechot, P; Vona, G; Brechot, C
      Circulating tumorous cells in patients with hepatocellular carcinoma. Clinical impact and future directions

      SEMINARS IN CANCER BIOLOGY
    21. Hegenbarth, S; Gerolami, R; Protzer, U; Tran, PL; Brechot, C; Gerken, G; Knolle, PA
      Liver sinusoidal endothelial cells are not permissive for adenovirus type 5

      HUMAN GENE THERAPY
    22. Chami, M; Gozuacik, D; Saigo, K; Capiod, T; Falson, P; Lecoeur, H; Urashima, T; Beckmann, J; Gougeon, ML; Claret, M; le Maire, M; Brechot, C; Paterlini-Brechot, P
      Hepatitis B virus-related insertional mutagenesis implicates SERCA1 gene in the control of apoptosis

      ONCOGENE
    23. Gerolami, R; Uch, R; Jordier, F; Chapel, S; Bagnis, C; Brechot, C; Mannoni, P
      Gene transfer to hepatocellular carcinoma: Transduction efficacy and transgene expression kinetics by using retroviral and lentiviral vectors

      CANCER GENE THERAPY
    24. Bilbao, R; Gerolami, R; Bralet, MP; Qian, C; Tran, PL; Tennant, B; Prieto, J; Brechot, C
      Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir therapy of hepatocellular carcinoma: The woodchuck animal model

      CANCER GENE THERAPY
    25. Soussan, P; Gareau, F; Brechot, C; Kremsdorf, D
      A new hepatitis B virus protein

      M S-MEDECINE SCIENCES
    26. Nalpas, B; Zylberberg, H; Dubois, F; Presles, MA; Gillant, JC; Lienard, M; Delemotte, B; Brechot, C
      Prevalence of infection by hepatitis viruses in a rural area. Analysis according to risk factors and alcohol consumption

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    27. Perlemuter, G; Sabile, A; Brechot, C
      Interactions between hepatitis C virus and lipid liver metabolism

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    28. Desdouets, C; Brechot, C
      p27: a pleiotropic regulator of cellular phenotype and a target for cell cycle dysregulation in cancer

      PATHOLOGIE BIOLOGIE
    29. Cavalloni, G; Dane, A; Piacibello, W; Bruno, S; Lamas, E; Brechot, C; Aglietta, M
      The involvement of human-nuc gene in polyploidization of K562 cell line

      EXPERIMENTAL HEMATOLOGY
    30. Pol, S; Nalpas, B; Bourliere, M; Couzigou, P; Tran, A; Abergel, A; Zarski, JP; Berthelot, P; Brechot, C
      Combination of ribavirin and interferon-alfa surpasses high doses of interferon-alfa alone in patients with genotype-1b-related chronic hepatitis C

      HEPATOLOGY
    31. Pol, S; Michel, ML; Brechot, C
      Immune therapy of hepatitis B virus chronic infection

      HEPATOLOGY
    32. Zylberberg, H; Nalpas, B; Pol, S; Brechot, C; Viard, JP
      Is there a relationship between hepatitis C virus infection and antiretroviral-associated lipoatrophy?

      AIDS
    33. Zylberberg, H; Fontaine, H; Correas, JM; Carnot, F; Brechot, C; Pol, S
      Dilated bile duct in patients receiving narcotic substitution - An early report

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    34. Tuveri, R; Jaffredo, F; Lunel, F; Nalpas, B; Pol, S; Feray, C; Marcellin, P; Thibault, V; Delagneau, JF; Opolon, P; Scarpa, B; Brechot, C; Thiers, V
      Impact of TT virus infection in acute and chronic, viral- and non viral-related liver diseases

      JOURNAL OF HEPATOLOGY
    35. Zylberberg, H; Fontaine, H; Brechot, C; Pol, S
      Triggering of acute alcoholic hepatitis by alpha-interferon therapy? - Reply

      JOURNAL OF HEPATOLOGY
    36. Fontaine, H; Nalpas, B; Carnot, F; Brechot, C; Pol, S
      Effect of pregnancy on chronic hepatitis C: a case-control study

      LANCET
    37. Fontaine, H; Chaix, ML; Lagneau, JL; Brechot, C; Pol, S
      Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa

      LANCET
    38. Pol, S; Samuel, D; Cadranel, JF; Legendre, C; Bismuth, H; Brechot, C; Kreis, H
      Hepatitis and solid organ transplantation

      TRANSPLANTATION PROCEEDINGS
    39. Fontaine, H; Thiers, V; Chretien, Y; Zylberberg, H; Poupon, RE; Brechot, C; Legendre, C; Kreis, H; Pol, S
      HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients

      TRANSPLANTATION
    40. Mejean, A; Vona, G; Nalpas, B; Damotte, D; Brousse, N; Chretien, Y; Dufour, B; Lacour, B; Brechot, C; Paterlini-Brechot, P
      Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence

      JOURNAL OF UROLOGY
    41. Soussan, P; Garreau, F; Zylberberg, H; Ferray, C; Brechot, C; Kremsdorf, D
      In vivo expression of a new hepatitis B virus protein encoded by a splicedRNA

      JOURNAL OF CLINICAL INVESTIGATION
    42. Zylberberg, H; Benhamou, Y; Lagneaux, JL; Landau, A; Chaix, ML; Fontaine, H; Bochet, M; Poynard, T; Katlama, C; Pialoux, G; Brechot, C; Pol, S
      Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIVcoinfected subjects: an early report

      GUT
    43. Christa, L; Pauloin, A; Simon, MT; Stinnakre, MG; Fontaine, ML; Delpal, S; Ollivier-Bousquet, M; Brechot, C; Devinoy, E
      High expression of the human hepatocarcinoma-intestine-pancreas/pancreatic-associated protein (HIP/PAP) gene in the mammary gland of lactating transgenic mice - Secretion into the milk and purification of the HIP/PAP lectin

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    44. Winston, N; Bourgain-Guglielmetti, F; Ciemerych, MA; Kubiak, JZ; Senamaud-Beaufort, C; Carrington, M; Brechot, C; Sobczak-Thepot, J
      Early development of mouse embryos null mutant for the cyclin A2 gene occurs in the absence of maternally derived cyclin A2 gene products

      DEVELOPMENTAL BIOLOGY
    45. Gerolami, R; Cardoso, J; Lewin, M; Bralet, MP; Cunha, AS; Clement, O; Brechot, C; Tran, PL
      Evaluation of HSV-tk gene therapy in a rat model of chemically induced hepatocellular carcinoma by intratumoral and intrahepatic artery routes

      CANCER RESEARCH
    46. Zylberberg, H; Chaix, ML; Brechot, C
      Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha

      ANNALS OF INTERNAL MEDICINE
    47. Tuveri, R; Perret, JL; Delaporte, E; Nguemby-Mbina, C; D'Allones, LR; Henzel, D; Faivre, D; Scarpa, B; Contu, P; Colombo, M; Thiers, V; Brechot, C; Larouze, B
      Prevalence and genetic variants of Hepatitis GB-C/HG and TT viruses in Gabon, equatorial Africa

      AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
    48. Vona, G; Sabile, A; Louha, M; Sitruk, V; Romana, S; Schutze, K; Capron, F; Franco, D; Pazzagli, M; Vekemans, M; Lacour, B; Brechot, C; Paterlini-Brechot, P
      Isolation by size of epithelial tumor cells - A new method for the immunomorphological and molecular characterization of circulating tumor cells

      AMERICAN JOURNAL OF PATHOLOGY
    49. Pol, S; Michel, ML; Brechot, C
      Immune therapy of hepatitis B virus (HBV) chronic infection. European experience

      ACTA GASTRO-ENTEROLOGICA BELGICA
    50. Kirk, GD; Camus-Randon, AM; Mendy, M; Goedert, JJ; Merle, P; Trepo, C; Brechot, C; Hainaut, P; Montesano, R
      Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from the Gambia

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    51. Poynard, T; Daurat, V; Chevret, S; Moussalli, J; Degos, F; Bailly, F; Borotto, E; Buffet, C; Bartolomei-Portal, I; Richardet, JP; Riachi, G; Calmus, Y; Brechot, C; Vidaud, M; Olivi, M; Bedossa, P; Riffaud, PC; Chastang, C
      A short induction regimen of interferon-alpha is not effective for treatment of relapse in chronic hepatitis C: a randomized trial

      JOURNAL OF VIRAL HEPATITIS
    52. Sirma, H; Giannini, C; Poussin, K; Paterlini, P; Kremsdorf, D; Brechot, C
      Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx

      ONCOGENE
    53. McIntyre, M; Desdouets, C; Senamaud-Beaufort, C; Laurent-Winter, C; Lamas, E; Brechot, C
      Differential expression of the cyclin-dependent kinase inhibitor P27 in primary hepatocytes in early-mid G1 and G1/S transitions

      ONCOGENE
    54. Abergel, C; Chenivesse, S; Stinnakre, MG; Guasco, S; Brechot, C; Claverie, JM; Devinoy, E; Christa, L
      Crystallization and preliminary crystallographic study of HIP/PAP, a humanC-lectin overexpressed in primary liver cancers

      ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
    55. Rosmorduc, O; Paterlini, P; Poupon, R; Brechot, C
      Hepatitis viruses and hepatocellular carcinoma.

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    56. Bluteau, O; Legoix, P; Bayer, J; Bioulac-Sage, P; Flejou, JF; Capron, F; Monges, G; Brechot, C; Thomas, G; Laurent-Puig, P; Zucman-Rossi, J
      Semi-automated quantitative method for detecting the loss of heterozygosity at chromosome 4 in hepatocellular carcinoma

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    57. Sabile, A; Perlemuter, G; Bono, F; Kohara, K; Demaugre, F; Kohara, M; Matsuura, Y; Miyamura, T; Brechot, C; Barba, G
      Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates

      HEPATOLOGY
    58. Bonura, C; Paterlini-Brechot, P; Brechot, C
      Structure and expression of Tg737, a putative tumor suppressor gene, in human hepatocellular carcinomas

      HEPATOLOGY
    59. Loriot, MA; Bronowicki, JP; Lagorce, D; Lakehal, F; Persico, T; Barba, G; Mergey, M; Vons, C; Franco, D; Belghiti, J; Giacca, M; Housset, C; Brechot, C
      Permissiveness of human biliary epithelial cells to infection by hepatitisC virus

      HEPATOLOGY
    60. Louha, M; Nicolet, J; Zylberberg, H; Sabile, A; Vons, C; Vona, G; Poussin, K; Tournebize, M; Capron, F; Pol, S; Franco, D; Lacour, B; Brechot, C; Paterlini-Brechot, P
      Liver resection and needle liver biopsy cause hematogenous dissemination of liver cells

      HEPATOLOGY
    61. Weil, R; Sirma, H; Giannini, C; Kremsdorf, D; Bessia, C; Dargemont, C; Brechot, C; Israel, A
      Direct association and nuclear import of the hepatitis B virus X protein with the NF-kappa B inhibitor I kappa B alpha

      MOLECULAR AND CELLULAR BIOLOGY
    62. Zylberberg, H; Pol, S; Thiers, V; Chaix, ML; Lagorce, D; Brechot, C; Nalpas, B; Berthelot, P
      Significance of repeatedly normal aminotransferase activities in HCV-infected patients

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    63. Zignego, AL; Brechot, C
      Extrahepatic manifestations of HCV infection: facts and controversies

      JOURNAL OF HEPATOLOGY
    64. Pol, S; Couzigou, P; Bourliere, M; Abergel, A; Combis, JM; Larrey, D; Tran, A; Moussalli, J; Poupon, R; Berthelot, P; Brechot, C
      A randomized trial of ribavirin and interferon-alpha vs. interferon-alpha alone in patients with chronic hepatitis C who were non-responders to a previous treatment

      JOURNAL OF HEPATOLOGY
    65. Marcellin, P; Alberti, A; Dusheiko, G; Esteban, R; Manns, M; Shouval, D; Weiland, O; Williams, R; Benhamou, JP; Rodes, J; Alter, H; Bismuth, H; Desmet, V; Guardia, J; Heathcote, J; Lok, A; Maddrey, WC; Zum Buschenfelde, KHM; Pagliaro, L; Paumgartner, G; Sherlock, S; Abrignani, S; Alberti, A; Alter, M; Bonino, F; Bortolotti, F; Brechot, C; de Moura, MC; Carreno, V; Colombo, M; Craxi, A; Davis, G; De Francesco, R; Degos, F; Di Bisceglie, A; Dienes, H; Dusheiko, G; Esteban, J; Esteban, R; Farci, P; Ferrari, C; Foster, G; Hadziyannis, S; Hoofnagle, J; Koff, R; Lavanchy, D; Lindsay, K; Lunel, F; Manns, M; Marcellin, P; Mondelli, M; Nalpas, B; Naoumov, N; Pawlotsky, JM; Pol, S; Pontisso, P; Poynard, T; Prieto, J; Rizzetto, M; Roggendorf, M; Moreno, MR; Samuel, D; Sanchez-Tapias, J; Schalm, S; Shouval, D; Simmonds, P; Soriano, V; Tassopoulos, N; Thomas, H; Trepo, C; Van der Poel, CL; Vogel, W; Weiland, O; Wejstal, R; Williams, R; Wright, T; Zanetti, A; Zarski, JP; Zeuzem, S; Zoulim, F
      EASL International Consensus Conference on Hepatitis C - Paris, 26-27 February 1999 - Consensus statement (Reprinted from Journal of Hematology, vol 30, pg 956-961, 1999)

      JOURNAL OF HEPATOLOGY
    66. Pol, S; Zylberberg, H; Fontaine, H; Brechot, C
      Treatment of chronic hepatitis C in special groups

      JOURNAL OF HEPATOLOGY
    67. Brechot, C
      The direct interplay between HCVNS5A protein and interferon transduction signal: from clinical to basic science

      JOURNAL OF HEPATOLOGY
    68. Zylberberg, H; Fontaine, H; Thepot, V; Nalpas, B; Brechot, C; Pol, S
      Triggering of acute alcoholic hepatitis by alpha-interferon therapy

      JOURNAL OF HEPATOLOGY
    69. Zylberberg, H; Rimaniol, AC; Pol, S; Masson, A; De Groote, D; Berthelot, P; Bach, JF; Brechot, C; Zavala, F
      Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity

      JOURNAL OF HEPATOLOGY
    70. Couillin, I; Pol, S; Mancini, M; Driss, F; Brechot, C; Tiollais, P; Michel, ML
      Specific vaccine therapy in chronic hepatitis B: Induction of T cell proliferative responses specific for envelope antigens

      JOURNAL OF INFECTIOUS DISEASES
    71. Rosmorduc, O; Sirma, H; Soussan, P; Gordien, E; Lebon, P; Horisberger, M; Brechot, C; Kremsdorf, D
      Inhibition of interferon-inducible MxA protein expression by hepatitis B virus capsid protein

      JOURNAL OF GENERAL VIROLOGY
    72. Poussin, K; Dienes, H; Sirma, H; Urban, S; Beaugrand, M; Franco, D; Schirmacher, P; Brechot, C; Brechot, PP
      Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas

      INTERNATIONAL JOURNAL OF CANCER
    73. Zylberberg, H; Thiers, V; Lagorce, D; Squadrito, G; Leone, F; Berthelot, P; Brechot, C; Pol, S
      Epidemiological and virological analysis of couples infected with hepatitis C virus

      GUT
    74. Desdouets, C; Thoresen, GH; Senamaud-Beaufort, C; Christoffersen, T; Brechot, C; Sobczak-Thepot, J
      cAMP-dependent positive control of cyclin A2 expression during G1/S transition in primary hepatocytes

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    75. Christa, L; Simon, MT; Brezault-Bonnet, C; Bonte, E; Carnot, F; Zylberberg, H; Franco, D; Capron, F; Roskams, T; Brechot, C
      Hepatocarcinoma-intestine-pancreas/pancreatic associated protein (HIP/PAP)is expressed and secreted by proliferating ductules as well as by hepatocarcinoma and cholangiocarcinoma cells

      AMERICAN JOURNAL OF PATHOLOGY
    76. Lasserre, C; Colnot, C; Brechot, C; Poirier, F
      HIP/PAP gene, encoding a C-type lectin overexpressed in primary liver cancer, is expressed in nervous system as well as in intestine and pancreas of the postimplantation mouse embryo

      AMERICAN JOURNAL OF PATHOLOGY
    77. Pol, S; Brechot, C
      Treatment of chronic hepatitis C

      ACTA GASTRO-ENTEROLOGICA BELGICA
    78. Sabile, A; Louha, M; Bonte, E; Poussin, K; Vona, G; Mejean, A; Chretien, Y; Bougas, L; Lacour, BR; Capron, F; Roseto, A; Brechot, C; Paterlini-Brechot, P
      Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection

      AJCP. American journal of clinical pathology
    79. THIERS V; POL S; PERSICO T; CARNOT F; ZYLBERBERG H; BERTHELOT P; BRECHOT C; NALPAS B
      HEPATITIS-G VIRUS-INFECTION IN HEPATITIS-C VIRUS-POSITIVE PATIENTS CO-INFECTED OR NOT WITH HEPATITIS-B VIRUS AND OR HUMAN-IMMUNODEFICIENCY-VIRUS/

      Journal of viral hepatitis
    80. LUNEL F; STUYVER L; BRECHOT C; MAERTENS G
      REVIEW ON HEPATITIS-C VIRUS - VARIABILITY AND CONSEQUENCES

      Transfusion clinique et biologique
    81. ZYLBERBERG H; PIALOUX G; CARNOT P; LANDAU A; BRECHOT C; POL S
      RAPIDLY EVOLVING HEPATITIS-C VIRUS-RELATED CIRRHOSIS IN A HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENT RECEIVING TRIPLE ANTIRETROVIRAL THERAPY

      Clinical infectious diseases
    82. ZYLBERBERG H; CHAIX ML; RABIAN C; ROUZIOUX C; AULONG B; BRECHOT C; VIARD JP; POL S
      TRITHERAPY FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION DOES NOT MODIFYREPLICATION OF HEPATITIS-C VIRUS IN COINFECTED SUBJECTS

      Clinical infectious diseases
    83. GEROLAMI R; CARDOSO J; BRALET MP; CUENOD CA; CLEMENT O; TRAN PL; BRECHOT C
      ENHANCED IN-VIVO ADENOVIRUS-MEDIATED GENE-TRANSFER TO RAT HEPATOCARCINOMAS BY SELECTIVE ADMINISTRATION INTO THE HEPATIC-ARTERY

      Gene therapy
    84. SIRMA H; WEIL R; ROSMORDUC O; URBAN S; ISRAEL A; KREMSDORF D; BRECHOT C
      CYTOSOL IS THE PRIME COMPARTMENT OF HEPATITIS-B VIRUS-X PROTEIN WHEREIT COLOCALIZES WITH THE PROTEASOME

      Oncogene
    85. BERASAIN C; PATIL D; PERARA E; HUANG SM; MOULY H; BRECHOT C
      ONCOGENIC ACTIVATION OF A HUMAN CYCLIN A2 TARGETED TO THE ENDOPLASMIC-RETICULUM UPON HEPATITIS-B VIRUS GENOME INSERTION

      Oncogene
    86. NALPAS B; POL S; THEPOT V; ZYLBERBERG H; BERTHELOT P; BRECHOT C
      RELATIONSHIP BETWEEN EXCESSIVE ALCOHOL-DRINKING AND VIRAL-INFECTIONS

      Alcohol and alcoholism
    87. PAYRAUDEAU V; SARSAT JP; SOBCZAK J; BRECHOT C; ALBALADEJO V
      CYCLIN A(2) AND C-MYC MESSENGER-RNA EXPRESSION IN ETHINYL ESTRADIOL-INDUCED LIVER PROLIFERATION

      Molecular and cellular endocrinology
    88. KNOLLE PA; GEROLAMI R; NASSAL M; BRECHOT C; GERKEN G
      LIVER SINUSOIDAL ENDOTHELIAL-CELLS ARE NOT PERMISSIVE FOR ADENOVIRUS INFECTION IMPLICATIONS FOR GENE-THERAPY OF HEPATOCELLULAR-CARCINOMA

      Hepatology
    89. FONTAINE H; THIERS V; ZYLBERBERG H; BRECHOT C; POL S
      HBV RESISTANCES LAMIVUDINE ACCORDING TO DAILY DOSAGE AND IMMUNE STATUS

      Hepatology
    90. LOUHA M; NICOLET J; SABILE M; ZYLBERBERG H; VONS C; VONA G; CAPRON F; POUSSIN K; POL S; NALPAS SB; FRANCO D; BRECHOT C; PATERLINI P
      IATROGENIC SPREADING OF LIVER-DERIVED CELLS BY LIVER RESECTION AND NEEDLE-BIOPSY IN PATIENTS WITH PRIMARY LIVER-CANCER

      Hepatology
    91. GORDIEN E; ROSMORDUC O; SIRMA H; BRECHOT C; KREMSDORF D
      INHIBITION OF HEPATITIS-B VIRUS-REPLICATION BY THE HUMAN MXA PROTEINS

      Hepatology
    92. FONTAINE H; NAIPAS B; POULET B; CARNOT F; ZYLBERBERG H; BRECHOT C; POL S
      INITIAL HISTOLOGICAL SEVERITY PREDICTS UNFAVORABLE EVOLUTION IN HCV POSITIVE PATIENTS

      Hepatology
    93. ZYLBERBERG H; FONTAINE H; CORREAS JM; CARNOT F; BRECHOT C; POL S
      ENLARGED BILE-DUCT IN PATIENTS RECEIVING NARCOTIC SUBSTITUTION - AN EARLY REPORT

      Hepatology
    94. ZYLBERBERG H; LANDAU A; CHAIX ML; FONTAINE H; PIALOUX G; BRECHOT C; POL S
      RIBAVIRIN GOES NOT MODIFY HIV REPLICATION IN HCV-HIV COINFECTED SUBJECTS UNDER ANTIRETROVIRAL REGIMEN

      Hepatology
    95. CHAMI M; SAIGO K; GOZUACIK D; POUSSIN K; FALSON P; TORCHARD D; CLEPET C; GYAPAY G; CAUDRON B; URASHIMA T; KEW M; ISONO K; LEMARIE M; BECKMAN J; WEISSENBACH J; BRECHOT C; PATERLINI P
      HBV RELATED INSERTIONAL MUTAGENESIS LEADS TO HYPEREXPRESSION OF A HBV-X SERCA-1 HYBRID PROTEIN IN A HUMAN HEPATOCELLULAR-CARCINOMA

      Hepatology
    96. SOUSSAN P; GARREAU F; BRECHOT C; KREMSDORF D
      IN-VITRO EXPRESSION OF A NEW HBV PROTEIN, GENERATED BY A SINGLY SPLICED HBV MESSENGER-RNA (HBSP), INDUCES APOPTOSIS

      Hepatology
    97. SIRMA H; WEIL R; GIANNINI C; KREMSDORF D; BRECHOT C; ISRAEL A
      HEPATITIS-B VIRUS X-PROTEIN INTERACTS WITH THE NES-SEQUENCE OF NF-KAPPA-B INHIBITOR I-KAPPA-BA - IMPLICATIONS FOR NF-KAPPA-B ACTIVATION

      Hepatology
    98. POL S; DRISS F; COUILLIN I; DENIS J; TIOLLAIS P; MICHEL ML; BRECHOT C
      A CONTROLLED-STUDY OF ANTI-HBV VACCINE THERAPY IN CHRONIC HEPATITIS-BINFECTION

      Hepatology
    99. POL S; BERTHELOT P; BRECHOT C
      RIBAVIRIN PLUS INTERFERON-ALPHA-2B (ALPHA-INF) COMBINATION SHOWS INCREASED EFFICIENCY COMPARED TO HIGH-DOSES ALPHA-INF, ALONE IN NAIVE PATIENTS INFECTED BY GENOTYPE 1B

      Hepatology
    100. LEBRAY P; ZYLBERBERG H; HUE S; POULET B; BRECHOT C; POL S; CAILLATZUCKMAN S
      HFE GENE-MUTATIONS HAVE NO MAJOR IMPLICATIONS IN CHRONIC HEPATITIS-C

      Hepatology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 15:29:00